BackgroundBipolar disorder and schizophrenia are associated with increased mortality
relative to the general population. There is an international emphasis on decreasing this …

AIM: To assess the prevalence of Coronary Heart Disease (CHD) and Metabolic Syndrome
(MS) in patients treated with antipsychotics. METHODS: Retrospective, cross-sectional …

OBJECTIVE: Standardized mortality rates are elevated in schizophrenia compared to the
general population. The incidence of coronary heart disease (CHD) and the relative …

Over the last decade, we have learned a great deal about the epidemiology of
schizophrenia. New data have accumulated, and systematic reviews have enabled us to …

AIM: We analysed the impact of tobacco smoking over several healthy lifestyle habits along
with the impact on 10-years cardiovascular event (CVE) risk in the CLAMORS schizophrenia …

BACKGROUND: Antipsychotic medication is the cornerstone of schizophrenia treatment.
The impact of long-term exposure to antipsychotics on life-expectancy has recently received …

Background Schizophrenia has a variety of clinical profiles, disabilities and outcomes
requiring responsive management and the devotion of considerable resources. The primary …

Previous reports regarding risk factors for suicide in schizophrenia have been inconclusive.
We performed a matched case-control study of in-patient-treated schizophrenia patients in …

Background Patients with schizophrenia represent a vulnerable, underserved, and
undertreated population who have been neglected in health disparities work. Understanding …

The excess mortality in schizophrenia has received much focus. Future studies should
explore the reasons for the high rates of natural causes of death, while aiming to disentangle …